Opportunities for cannabis in Cape Town’s pharmaceutical industry

Report an error

Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

The document identifies Cape Town as a potential medicinal cannabis hub, leveraging its existing pharmaceutical infrastructure and medical tourism status. It outlines opportunities across the value chain, from cultivation to agro-technology services, while noting significant barriers such as electricity instability (load shedding), financing difficulties due to licensing requirements, and a reliance on volatile international export markets.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • The global cannabis sector was valued at $51.28 billion in 2023, and in South Africa, President Cyril Ramaphosa estimated the industry could be worth R406.3 billion and create over 130,000 new jobs by 2026.
  • Investment opportunities in Cape Town extend beyond cultivation and processing to include agro-technology suppliers providing lighting, fertigation, drip irrigation, and water treatment.
  • The Epping industrial zone is identified as a strategic location for medicinal cannabis start-ups due to available warehouses for indoor facilities and its proximity (approximately 6 km) to Cape Town International Airport, which facilitates exports.
  • Cape Town has a competitive advantage in medical tourism due to its world-renowned doctors, English-speaking personnel, and favorable exchange rates; however, the lack of a national wellness strategy is viewed as a lost opportunity.
  • Production costs vary significantly by method: indoor production has the highest capital investment cost at 807 USD/m2, followed by greenhouses (538 USD/m2) and outdoor production (108 USD/m2).
  • Load shedding poses a severe risk to productivity and product quality; indoor facilities are mitigating this by investing in solar PV systems and battery storage, while greenhouse producers adjust schedules or use diesel generators.
  • Financial barriers exist because the South African Health Products Regulatory Authority (SAHPRA) requires facilities to be fully set up before issuing a license, making financiers reluctant to provide funding due to the risk of license denial.
  • The industry is vulnerable to international market restrictions intended to protect domestic industries in other countries, highlighting the need for trade agreements and a stronger domestic market.

Cite the original document

APA
GreenCape (n.d.). Opportunities for cannabis in Cape Town’s pharmaceutical industry. https://greencape.co.za/wp-content/uploads/2023/06/Cape-Towns-pharmaceutical-industry.pdf
Chicago
GreenCape. Opportunities for cannabis in Cape Town’s pharmaceutical industry. n.d. https://greencape.co.za/wp-content/uploads/2023/06/Cape-Towns-pharmaceutical-industry.pdf.
Wikipedia
{{cite report |author=GreenCape |title=Opportunities for cannabis in Cape Town’s pharmaceutical industry |url=https://greencape.co.za/wp-content/uploads/2023/06/Cape-Towns-pharmaceutical-industry.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}
BibTeX
@techreport{greencapendopportunities, author = {{GreenCape}}, title = {{Opportunities for cannabis in Cape Town’s pharmaceutical industry}}, institution = {GreenCape}, url = {https://greencape.co.za/wp-content/uploads/2023/06/Cape-Towns-pharmaceutical-industry.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }

Full text

Collected · Record updated